US Stock MarketDetailed Quotes

CATX Perspective Therapeutics

Watchlist
  • 1.5600
  • +0.0600+4.00%
Close May 28 16:00 ET
  • 1.5500
  • -0.0100-0.64%
Post 19:56 ET
971.30MMarket Cap-8297P/E (TTM)

Perspective Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Jun 30, 2022
(Q3)Mar 31, 2022
(Q2)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
242.43%13.85M
-506.52%-36.91M
-211.59%-9.01M
-610.97%-10.11M
-8.07M
-9.72M
-114.52%-6.09M
-158.59%-2.89M
-128.99%-1.42M
-72.76%-1.31M
Net income from continuing operations
-3,211.05%-12.28M
-534.06%-46.51M
-1,087.44%-24.68M
-668.82%-10.36M
---11.11M
---371K
-116.56%-7.34M
-95.85%-2.08M
-80.81%-1.35M
-84.79%-1.6M
Operating gains losses
-90.91%2K
-87.21%39K
--5K
--12K
--0
--22K
2,950.00%305K
----
----
----
Depreciation and amortization
92.22%346K
585.51%946K
303.08%262K
304.69%259K
--245K
--180K
-7.38%138K
54.76%65K
77.78%64K
62.16%60K
Deferred tax
--0
---2.65M
--7.85M
--0
--0
---10.5M
----
----
----
----
Other non cash items
-1,440.00%-268K
2,414.52%4.31M
19,122.73%4.23M
277.78%68K
---12K
--20K
-358.33%-186K
4.76%22K
12.50%18K
11.76%19K
Change In working capital
5,845.70%25.4M
617.50%2.3M
287.67%1.98M
-73.25%-544K
--1.3M
---442K
577.61%320K
-328.46%-1.05M
-1,156.00%-314K
194.12%32K
-Change in receivables
16,700.00%166K
-273.88%-426K
-110.90%-58K
-25.35%-618K
--251K
---1K
690.32%245K
8,766.67%532K
-75.44%-493K
1,175.00%255K
-Change in inventory
-78.91%27K
572.37%359K
105.09%102K
34.52%113K
--16K
--128K
72.26%-76K
-1,406.77%-2M
250.00%84K
295.45%43K
-Change in prepaid assets
-156.67%-154K
-30.52%-325K
-400.89%-337K
3,908.33%457K
---385K
---60K
-344.64%-249K
11,100.00%112K
93.41%-12K
-314.02%-229K
-Change in payables and accrued expense
-419.25%-2.64M
572.00%2.69M
642.16%2.27M
-563.55%-496K
--1.42M
---509K
72.41%400K
355.00%306K
-78.34%107K
73.38%-37K
-Change in other working capital
--28M
----
----
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
242.43%13.85M
-506.52%-36.91M
-211.59%-9.01M
-610.97%-10.11M
---8.07M
---9.72M
-114.52%-6.09M
-158.59%-2.89M
-128.99%-1.42M
-72.76%-1.31M
Investing cash flow
Cash flow from continuing investing activities
-287.23%-47.3M
184.51%24.37M
27.64%-89K
-773.08%-227K
-573K
25.26M
-6,933.90%-28.84M
10.87%-123K
73.74%-26K
-35.00%-81K
Net PPE purchase and sale
-4,413.43%-9.07M
-609.93%-1.07M
15.24%-89K
-773.08%-227K
---555K
---201K
60.26%-151K
8.70%-105K
71.74%-26K
-35.00%-81K
Net business purchase and sale
--0
--2.7M
--0
--0
--0
--2.7M
----
----
----
----
Net investment purchase and sale
-267.92%-38.23M
200.33%22.76M
--0
--0
--0
--22.76M
---22.69M
----
----
----
Net other investing changes
----
99.70%-18K
--0
--0
----
----
-19,900.00%-6M
----
----
----
Cash from discontinued investing activities
Investing cash flow
-287.23%-47.3M
184.51%24.37M
27.64%-89K
-773.08%-227K
---573K
--25.26M
-6,933.90%-28.84M
10.87%-123K
73.74%-26K
-35.00%-81K
Financing cash flow
Cash flow from continuing financing activities
208,010.00%166.33M
2,703.57%785K
352K
1K
512K
-80K
-99.96%28K
0
0
56K
Net issuance payments of debt
20.00%-12K
---68K
---12K
---21K
---20K
---15K
----
----
----
----
Net common stock issuance
--53.27M
3,178.57%918K
--364K
--22K
--532K
--0
-99.96%28K
--0
--0
--56K
Cash dividends paid
----
----
----
----
----
----
--0
--0
--0
----
Proceeds from stock option exercised by employees
--10.21M
----
----
----
----
--0
----
----
----
----
Net other financing activities
158,353.85%102.87M
---65K
--0
--0
--0
---65K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
208,010.00%166.33M
2,703.57%785K
--352K
--1K
--512K
---80K
-99.96%28K
--0
--0
--56K
Net cash flow
Beginning cash position
-55.51%9.42M
-62.24%21.18M
-69.26%18.17M
-52.92%28.5M
--36.63M
--21.18M
2,079.25%56.07M
-9.13%59.09M
519.78%60.53M
2,815.74%61.87M
Current changes in cash
759.56%132.88M
66.32%-11.76M
-190.15%-8.75M
-613.81%-10.34M
---8.13M
--15.46M
-156.80%-34.9M
-197.53%-3.01M
-102.62%-1.45M
-117.50%-1.34M
End cash Position
288.43%142.3M
-55.51%9.42M
-83.20%9.42M
-69.26%18.17M
--28.5M
--36.63M
-66.92%21.18M
-12.40%56.07M
-9.13%59.09M
519.78%60.53M
Free cash flow
148.13%4.78M
-509.03%-37.99M
-203.64%-9.1M
-613.88%-10.34M
---8.63M
---9.92M
-93.82%-6.24M
-142.98%-3M
-102.80%-1.45M
-70.00%-1.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Jun 30, 2022(Q3)Mar 31, 2022(Q2)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 242.43%13.85M-506.52%-36.91M-211.59%-9.01M-610.97%-10.11M-8.07M-9.72M-114.52%-6.09M-158.59%-2.89M-128.99%-1.42M-72.76%-1.31M
Net income from continuing operations -3,211.05%-12.28M-534.06%-46.51M-1,087.44%-24.68M-668.82%-10.36M---11.11M---371K-116.56%-7.34M-95.85%-2.08M-80.81%-1.35M-84.79%-1.6M
Operating gains losses -90.91%2K-87.21%39K--5K--12K--0--22K2,950.00%305K------------
Depreciation and amortization 92.22%346K585.51%946K303.08%262K304.69%259K--245K--180K-7.38%138K54.76%65K77.78%64K62.16%60K
Deferred tax --0---2.65M--7.85M--0--0---10.5M----------------
Other non cash items -1,440.00%-268K2,414.52%4.31M19,122.73%4.23M277.78%68K---12K--20K-358.33%-186K4.76%22K12.50%18K11.76%19K
Change In working capital 5,845.70%25.4M617.50%2.3M287.67%1.98M-73.25%-544K--1.3M---442K577.61%320K-328.46%-1.05M-1,156.00%-314K194.12%32K
-Change in receivables 16,700.00%166K-273.88%-426K-110.90%-58K-25.35%-618K--251K---1K690.32%245K8,766.67%532K-75.44%-493K1,175.00%255K
-Change in inventory -78.91%27K572.37%359K105.09%102K34.52%113K--16K--128K72.26%-76K-1,406.77%-2M250.00%84K295.45%43K
-Change in prepaid assets -156.67%-154K-30.52%-325K-400.89%-337K3,908.33%457K---385K---60K-344.64%-249K11,100.00%112K93.41%-12K-314.02%-229K
-Change in payables and accrued expense -419.25%-2.64M572.00%2.69M642.16%2.27M-563.55%-496K--1.42M---509K72.41%400K355.00%306K-78.34%107K73.38%-37K
-Change in other working capital --28M------------------------------------
Cash from discontinued investing activities
Operating cash flow 242.43%13.85M-506.52%-36.91M-211.59%-9.01M-610.97%-10.11M---8.07M---9.72M-114.52%-6.09M-158.59%-2.89M-128.99%-1.42M-72.76%-1.31M
Investing cash flow
Cash flow from continuing investing activities -287.23%-47.3M184.51%24.37M27.64%-89K-773.08%-227K-573K25.26M-6,933.90%-28.84M10.87%-123K73.74%-26K-35.00%-81K
Net PPE purchase and sale -4,413.43%-9.07M-609.93%-1.07M15.24%-89K-773.08%-227K---555K---201K60.26%-151K8.70%-105K71.74%-26K-35.00%-81K
Net business purchase and sale --0--2.7M--0--0--0--2.7M----------------
Net investment purchase and sale -267.92%-38.23M200.33%22.76M--0--0--0--22.76M---22.69M------------
Net other investing changes ----99.70%-18K--0--0---------19,900.00%-6M------------
Cash from discontinued investing activities
Investing cash flow -287.23%-47.3M184.51%24.37M27.64%-89K-773.08%-227K---573K--25.26M-6,933.90%-28.84M10.87%-123K73.74%-26K-35.00%-81K
Financing cash flow
Cash flow from continuing financing activities 208,010.00%166.33M2,703.57%785K352K1K512K-80K-99.96%28K0056K
Net issuance payments of debt 20.00%-12K---68K---12K---21K---20K---15K----------------
Net common stock issuance --53.27M3,178.57%918K--364K--22K--532K--0-99.96%28K--0--0--56K
Cash dividends paid --------------------------0--0--0----
Proceeds from stock option exercised by employees --10.21M------------------0----------------
Net other financing activities 158,353.85%102.87M---65K--0--0--0---65K----------------
Cash from discontinued financing activities
Financing cash flow 208,010.00%166.33M2,703.57%785K--352K--1K--512K---80K-99.96%28K--0--0--56K
Net cash flow
Beginning cash position -55.51%9.42M-62.24%21.18M-69.26%18.17M-52.92%28.5M--36.63M--21.18M2,079.25%56.07M-9.13%59.09M519.78%60.53M2,815.74%61.87M
Current changes in cash 759.56%132.88M66.32%-11.76M-190.15%-8.75M-613.81%-10.34M---8.13M--15.46M-156.80%-34.9M-197.53%-3.01M-102.62%-1.45M-117.50%-1.34M
End cash Position 288.43%142.3M-55.51%9.42M-83.20%9.42M-69.26%18.17M--28.5M--36.63M-66.92%21.18M-12.40%56.07M-9.13%59.09M519.78%60.53M
Free cash flow 148.13%4.78M-509.03%-37.99M-203.64%-9.1M-613.88%-10.34M---8.63M---9.92M-93.82%-6.24M-142.98%-3M-102.80%-1.45M-70.00%-1.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg